GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (STU:LHU) » Definitions » COGS-to-Revenue

LeMaitre Vascular (STU:LHU) COGS-to-Revenue : 0.31 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is LeMaitre Vascular COGS-to-Revenue?

LeMaitre Vascular's Cost of Goods Sold for the three months ended in Mar. 2024 was €15.5 Mil. Its Revenue for the three months ended in Mar. 2024 was €49.2 Mil.

LeMaitre Vascular's COGS to Revenue for the three months ended in Mar. 2024 was 0.31.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. LeMaitre Vascular's Gross Margin % for the three months ended in Mar. 2024 was 68.56%.


LeMaitre Vascular COGS-to-Revenue Historical Data

The historical data trend for LeMaitre Vascular's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular COGS-to-Revenue Chart

LeMaitre Vascular Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.35 0.34 0.35 0.34

LeMaitre Vascular Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.36 0.35 0.32 0.31

LeMaitre Vascular COGS-to-Revenue Calculation

LeMaitre Vascular's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=60.921 / 177.425
=0.34

LeMaitre Vascular's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=15.468 / 49.2
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LeMaitre Vascular  (STU:LHU) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

LeMaitre Vascular's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 15.468 / 49.2
=68.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


LeMaitre Vascular COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LeMaitre Vascular (STU:LHU) Business Description

Traded in Other Exchanges
Address
63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

LeMaitre Vascular (STU:LHU) Headlines

No Headlines